Detalhe da pesquisa
1.
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C.
J Viral Hepat
; 29(10): 862-867, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737855
2.
[Analysis of a randomized, double-blind, double-dummy, controlled, multicenter study confirmed the similar therapeutic efficacies of entecavir maleate and entecavir for treatment of HBeAg-positive chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 21(12): 881-5, 2013 Dec.
Artigo
em Chinês
| MEDLINE | ID: mdl-24636286
3.
[A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of HBeAg-negative chronic hepatitis B: results at week 48].
Zhonghua Gan Zang Bing Za Zhi
; 20(7): 512-6, 2012 Jul.
Artigo
em Chinês
| MEDLINE | ID: mdl-23044236
4.
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C.
World J Clin Cases
; 10(28): 10085-10096, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36246814
5.
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks.
World J Clin Cases
; 9(18): 4690-4699, 2021 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34222435
6.
[Comparison of lamivudine or interferon monotherapy and sequential therapy in chronic hepatitis B: a random controlled trial].
Beijing Da Xue Xue Bao Yi Xue Ban
; 42(6): 739-45, 2010 Dec 18.
Artigo
em Chinês
| MEDLINE | ID: mdl-21170108
7.
[A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment].
Zhonghua Yi Xue Za Zhi
; 89(41): 2902-5, 2009 Nov 10.
Artigo
em Chinês
| MEDLINE | ID: mdl-20137646
8.
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48.
Medicine (Baltimore)
; 98(33): e16778, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31415381
9.
Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.
World J Gastroenterol
; 14(8): 1268-73, 2008 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18300356
10.
[Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 16(3): 198-202, 2008 Mar.
Artigo
em Chinês
| MEDLINE | ID: mdl-18364079
11.
Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.
Clin Infect Dis
; 44(4): 541-8, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17243057
12.
Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.
World J Gastroenterol
; 13(20): 2878-82, 2007 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17569128
13.
[A clinical study of adefovir dipivoxil in treating lamivudine refractory HBeAg-positive chronic hepatitis B].
Zhonghua Nei Ke Za Zhi
; 46(4): 294-7, 2007 Apr.
Artigo
em Chinês
| MEDLINE | ID: mdl-17637268
14.
[An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers].
Zhonghua Gan Zang Bing Za Zhi
; 15(8): 577-81, 2007 Aug.
Artigo
em Chinês
| MEDLINE | ID: mdl-17711625
15.
[A clinical study of adefovir dipivoxil, made in China, for treatment of hepatitis B e antigen-positive patients with chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 14(12): 898-901, 2006 Dec.
Artigo
em Chinês
| MEDLINE | ID: mdl-17196132
16.
[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 14(5): 323-6, 2006 May.
Artigo
em Chinês
| MEDLINE | ID: mdl-16732903
17.
[Foscarnet sodium for treatment in patients with severe chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 14(11): 814-6, 2006 Nov.
Artigo
em Chinês
| MEDLINE | ID: mdl-17125606
18.
Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
World J Gastroenterol
; 21(43): 12421-9, 2015 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604649
19.
Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect.
Jpn J Infect Dis
; 57(3): 91-6, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15218216
20.
Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study.
Hepatobiliary Pancreat Dis Int
; 3(3): 381-5, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15313673